Pulmonary Embolism Treatment Market by drug class, route of administration, Distribution Channel and Geography. Market Leaders are Accu-Break Pharmaceuticals, Daiichi Sankyo Company, Dong-A Socio Holdings, Hoffmann-La Roche, Genentech, Janssen Pharmaceuti

Precision Business Insights (PBI) in its report titled “Pulmonary Embolism Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis and Forecast 2017-2021” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The pulmonary embolism market size was accounted for US$ XX Mn in 2018 and anticipated to account for US$ XX Mn by 2025. Global incidence of cancer, rising global population, increasing global per capita healthcare expenditure drives the growth of market. However, due to introduction of novel oral anticoagulants and prohibition of techniques in the U.S. hinders the growth.

Pulmonary embolism market segmented on the basis of drug class, route of administration, and distribution channel.

V/Q Scan Segment Expected to Dominate the Market

The competition in the pulmonary embolism diagnostic market, especially V/Q Scan, is dominated by one big player at the global level, Cyclopharm, and at the regional level, in the US, the competition is dominated by Lantheus Holdings, Inc. (Xe-133).

Read more Insights at https://www.precisionbusinessinsights.com/market-reports/pulmonary-embolism-treatment-market/

North America, Accounts for Major Revenue Share for Pulmonary Embolism Market

Precision Business Insights (PBI) pulmonary embolism market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America accounted for major revenue share due to increased R&D investments, increased occurrence of cancer among the population, rising geriatric population. Moreover, improving economic conditions, rise in spending power, and better access to health care service fuels the market in Asia Pacific. Economic growth in countries such as Brazil is increasing research & development activities and expenditure on treatment in Latin America.

Drug Development Play Vital Role in Pulmonary Embolism Market

For instance, AstraZeneca, is developing a drug candidate called Brilliant Thales for the indication of cardiovascular events.

The key players in this report are Accu-Break Pharmaceuticals, Inc. (U.S.), Dong-A Socio Holdings Co. Ltd. (South Korea), Hoffmann-La Roche Ltd., Genentech, Inc. (U.S.), Janssen Pharmaceuticals, Inc (Belgium), Verseon Corp (U.S), Daiichi Sankyo Company Ltd (Japan)

Avail sample Brochure of the report at https://bit.ly/2VZNPVY

Detailed Segmentation

By Drug Class

o Anticoagulant
o Warfarin
o Heparin
o Low molecular-weight heparin
o Fondaparinux (Arixtra)
o Other
o Thrombolytics
o Reteplase
o Alteplase
o Others

By Route of Administration

o Oral
o Intravenous
o Subcutaneous

By Distribution Channel

o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Saudi Arabia
 Rest of MEA

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.